EMG and Delta Function in Standard RTSA vs Lateralization
EMGRTSA
Postoperative Deltoid EMG Activity and Function in Patients After Reverse Total Shoulder Arthroplasty: A Comparison of Standard Implantation Technique and Lateralization
1 other identifier
interventional
130
1 country
1
Brief Summary
Reverse total shoulder arthroplasty (RTSA) is a well-established method to treat patients with irreparable rotator cuff tears and glenohumeral osteoarthritis. The biomechanical principle implies a medialization and distalization of the center of rotation (COR). Deficiencies in internal and external rotation constitute frequently encountered functional problems. Some studies showed reduced activation of the posterior deltoid in EMG measurements, which may explain the inability to compensate these movements. Lateralized prosthetic designs demonstrated increased external rotation through an alteration of the deltoid's lever arm. The aim of the study is to investigate the impact of lateralization on functional outcome and deltoid EMG activity in comparison to a standard implantation technique.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 10, 2024
CompletedFirst Posted
Study publicly available on registry
March 11, 2026
CompletedStudy Start
First participant enrolled
June 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
May 7, 2026
May 1, 2026
1.2 years
August 10, 2024
May 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Delta Muscle activity (especially posterior Delta part)
The ratio between peak torque and EMG root mean square is measured
preoperative
Delta Muscle activity (especially posterior Delta part)
The ratio between peak torque and EMG root mean square is measured
6 weeks postoperative
Delta Muscle activity (especially posterior Delta part)
The ratio between peak torque and EMG root mean square is measured
3 months postoperative
Delta Muscle activity (especially posterior Delta part)
The ratio between peak torque and EMG root mean square is measured
6 months postoperative
Delta Muscle activity (especially posterior Delta part)
The ratio between peak torque and EMG root mean square is measured
1 year postoperative
Secondary Outcomes (11)
Range of movement (forward flexion, abduction, external rotation, extension)
preoperative
Range of movement (forward flexion, abduction, external rotation, extension)
6 weeks postoperative
Range of movement (forward flexion, abduction, external rotation, extension)
3 months postoperative
Range of movement (forward flexion, abduction, external rotation, extension)
6 months postoperative
Range of movement (forward flexion, abduction, external rotation, extension)
1 year postoperative
- +6 more secondary outcomes
Study Arms (2)
Standard Implantation Group
ACTIVE COMPARATORSubjects treated with a standard glenoid component of the used reverse total shoulder prosthesis
Lateralized Implantation Group
ACTIVE COMPARATORSubjects treated with a lateralized glenoid component of the used reverse total shoulder prosthesis
Interventions
Lateralization of glenoid component in reverse total shoulder arthroplasty via metal augment on the glenoid side with a thickness of at least 4mm
Implantation of a standard glenoid component without any lateralization via metal back on the glenoid site
Eligibility Criteria
You may qualify if:
- male/female, 60-85y
- diagnosis of Cuff tear arthropathy (CTA)
- irreparable rotator cuff tear
- severe osteoarthritis (OA)
- primary RSA
- verified rotator cuff tear in preoperative MRI
- absence of severe cognitive impairment
You may not qualify if:
- previous muscle transfer
- revision surgery
- highly dysplastic glenoid
- axillary nerve palsy
- upper limb radiculopathy
- cervical myelopathy
- degenerative muscular disease,
- previous proximal humeral fracture
- revision arthroplasty
- rheumatoid arthritis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Klinik Donaustadt
Vienna, Austria, 1220, Austria
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Robert Breuer, MD
Vienna HA
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 10, 2024
First Posted
March 11, 2026
Study Start
June 1, 2026
Primary Completion (Estimated)
August 1, 2027
Study Completion (Estimated)
December 1, 2027
Last Updated
May 7, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share